These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 17047333)
1. Matrix metalloproteinases and atherogenesis in dependence of age. Kunz J Gerontology; 2007; 53(2):63-73. PubMed ID: 17047333 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Johnson JL Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671 [TBL] [Abstract][Full Text] [Related]
3. Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling. Castro MM; Rizzi E; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF Matrix Biol; 2010 Apr; 29(3):194-201. PubMed ID: 19969080 [TBL] [Abstract][Full Text] [Related]
4. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Newby AC Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476 [TBL] [Abstract][Full Text] [Related]
5. Relevance of tenascin-C and matrix metalloproteinases in vascular abnormalities in murine hypoplastic lungs. Chinoy MR; Miller SA Biol Neonate; 2006; 90(3):185-96. PubMed ID: 16699260 [TBL] [Abstract][Full Text] [Related]
6. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Newby AC Cardiovasc Res; 2006 Feb; 69(3):614-24. PubMed ID: 16266693 [TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers. Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734 [TBL] [Abstract][Full Text] [Related]
9. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in atherothrombosis. Bäck M; Ketelhuth DF; Agewall S Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959 [TBL] [Abstract][Full Text] [Related]
11. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029 [TBL] [Abstract][Full Text] [Related]
12. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941 [TBL] [Abstract][Full Text] [Related]
13. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging. Vigetti D; Moretto P; Viola M; Genasetti A; Rizzi M; Karousou E; Pallotti F; De Luca G; Passi A FASEB J; 2006 Jun; 20(8):1118-30. PubMed ID: 16770011 [TBL] [Abstract][Full Text] [Related]
15. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
16. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats]. Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093 [TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus. Shukla V; Kumar Shakya A; Dhole TN; Misra UK Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541 [TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]